The facility was set up in the South African city of Cape Town in 2021 on the back of the success of revolutionary anti-Covid vaccines introduced by Pfizer/BioNTech and Moderna.
The hub has already established mRNA vaccine production at laboratory scale and is currently scaling up and validating production of Moderna jabs at commercial scale. The Covid-19 pandemic which erupted in early 2020 exposed Africa's huge dependence on imported vaccines. The Covid-19 pandemic provided a crucial testbed for the fledgling technology, demonstrating how a safe and effective vaccine could be created at lightning speed compared with years for traditional vaccines.